Retrospective cross sectional evaluation of the LIVERFASt Test for staging liver fibrosis in MASLD patients in NIDDK studies’ populations using liver biopsy
MASLD affects more than 25% of subjects of the general population and can progress to advanced fibrosis (AF) and cirrhosis […]